UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 17,
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Boundless Bio Charts.
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Boundless Bio Charts.

Audentes Therapeutics, Inc. News

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
Thursday 11 April 2024 (3 weeks ago) • Business Wire
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
Monday 8 April 2024 (3 weeks ago) • Business Wire

More Audentes Therapeutics, Inc. News Articles